{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T17:10:06Z","timestamp":1781889006579,"version":"3.54.5"},"reference-count":81,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jhep.2018.10.026","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T11:50:33Z","timestamp":1547553033000},"page":"305-313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":107,"title":["Current trials and novel therapeutic targets for alcoholic hepatitis"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3681-7285","authenticated-orcid":false,"given":"Ashwani K.","family":"Singal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7620-573X","authenticated-orcid":false,"given":"Vijay H.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2018.10.026_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2013.06.013","article-title":"Alcoholic hepatitis: current challenges and future directions","volume":"12","author":"Singal","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.10.026_b0010","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMra0805786","article-title":"Alcoholic hepatitis","volume":"360","author":"Lucey","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2018.10.026_b0015","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/acer.13108","article-title":"Diagnosis and treatment of alcoholic hepatitis: a systematic review","volume":"40","author":"Singal","year":"2016","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhep.2018.10.026_b0020","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","article-title":"Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA alcoholic hepatitis consortia","volume":"150","author":"Crabb","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.10.026_b0025","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/hep4.1119","article-title":"Prediction of histologic alcoholic hepatitis based on clinical presentation limits the need for liver biopsy","volume":"1","author":"Roth","year":"2017","journal-title":"Hepatol Commun."},{"key":"10.1016\/j.jhep.2018.10.026_b0030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrgastro.2015.35","article-title":"Alcoholic liver disease: mechanisms of injury and targeted treatment","volume":"12","author":"Louvet","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.10.026_b0035","doi-asserted-by":"crossref","first-page":"414","DOI":"10.14218\/JCTH.2017.00044","article-title":"Severe alcoholic hepatitis: atypical presentation with markedly elevated alkaline phosphatase","volume":"5","author":"Axley","year":"2017","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.jhep.2018.10.026_b0040","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jhep.2018.05.001","article-title":"Grand rounds: alcoholic hepatitis","volume":"69","author":"Singal","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.10.026_b0045","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMra1610570","article-title":"Use of liver imaging and biopsy in clinical practice","volume":"377","author":"Tapper","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2018.10.026_b0050","doi-asserted-by":"crossref","DOI":"10.1002\/hep.29080","article-title":"A prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis","author":"Bissonnette","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.10.026_b0055","doi-asserted-by":"crossref","DOI":"10.1002\/hep.29099","article-title":"Caspase-cleaved keratin-18 fragments increase during alcohol withdrawal and predict liver-related death in patients with alcoholic liver disease","author":"Mueller","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.10.026_b0060","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.gtc.2011.06.008","article-title":"Alcoholic hepatitis: prognostic models and treatment","volume":"40","author":"Singal","year":"2011","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jhep.2018.10.026_b0065","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.10.026_b0070","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.20503","article-title":"MELD accurately predicts mortality in patients with alcoholic hepatitis","volume":"41","author":"Dunn","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.10.026_b0075","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2014.01.018","article-title":"A histologic scoring system for prognosis of patients with alcoholic hepatitis","volume":"146","author":"Altamirano","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.10.026_b0080","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4254\/wjh.v3.i5.125","article-title":"General aspects of the treatment of alcoholic hepatitis","volume":"3","author":"Babineaux","year":"2011","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jhep.2018.10.026_b0085","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ajg.2017.469","article-title":"ACG clinical guideline: alcoholic liver disease","volume":"113","author":"Singal","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2018.10.026_b0090","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM197106172842404","article-title":"Corticosteroid therapy in severe alcoholic hepatitis. A double-blind drug trial","volume":"284","author":"Porter","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2018.10.026_b0095","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gut.2010.224097","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data","volume":"60","author":"Mathurin","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2018.10.026_b0100","first-page":"282","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"373","author":"Thursz","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2018.10.026_b0105","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.06.006","article-title":"Comparative effectiveness of pharmacological interventions for severe alcoholic hepatitis: a systematic review and network meta-analysis","volume":"149","author":"Singh","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.10.026_b0110","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.05.011","article-title":"Corticosteroids reduce risk of death within 28 days for patients with severe alcoholic hepatitis, compared with pentoxifylline or placebo-a meta-analysis of individual data from controlled trials","volume":"155","author":"Louvet","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.10.026_b0115","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.jhep.2015.03.006","article-title":"Trends in the management and burden of alcoholic liver disease","volume":"62","author":"Mathurin","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.10.026_b0120","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.10.026_b0125","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4292\/wjgpt.v4.i2.16","article-title":"Management practices of hepatitis C virus infected alcoholic hepatitis patients: a survey of physicians","volume":"4","author":"Singal","year":"2013","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"10.1016\/j.jhep.2018.10.026_b0130","first-page":"25","article-title":"Optimal management of alcoholic hepatitis","volume":"60","author":"Raff","year":"2014","journal-title":"Minerva Gastroenterol Dietol"},{"key":"10.1016\/j.jhep.2018.10.026_b0135","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1105703","article-title":"Early liver transplantation for severe alcoholic hepatitis","volume":"365","author":"Mathurin","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2018.10.026_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190823","article-title":"Liver transplantation for alcoholic hepatitis: a systematic review with meta-analysis","volume":"13","author":"Marot","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2018.10.026_b0145","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/hep.25544","article-title":"Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: exploratory analysis from the UNOS database","volume":"55","author":"Singal","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.10.026_b0150","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/lt.24208","article-title":"Liver transplantation for alcoholic hepatitis: a survey of liver transplant centers","volume":"21","author":"Hasanin","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2018.10.026_b0155","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1053\/j.gastro.2014.10.042","article-title":"Gut-liver axis in alcoholic liver disease","volume":"148","author":"Szabo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.10.026_b0160","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","article-title":"Pathological bacterial translocation in liver cirrhosis","volume":"60","author":"Wiest","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.10.026_b0165","article-title":"Alcohol-related changes in the intestinal microbiome influence neutrophil infiltration, inflammation and steatosis in early alcoholic hepatitis in mice","volume":"12","author":"Lowe","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2018.10.026_b0170","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrgastro.2017.71","article-title":"Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets","volume":"14","author":"Szabo","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.10.026_b0175","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jhep.2008.10.028","article-title":"Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats","volume":"50","author":"Keshavarzian","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.10.026_b0180","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cld.2012.08.009","article-title":"Nutrition in alcoholic liver disease","volume":"16","author":"Singal","year":"2012","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2018.10.026_b0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076522","article-title":"Dietary zinc deficiency exaggerates ethanol-induced liver injury in mice: involvement of intrahepatic and extrahepatic factors","volume":"8","author":"Zhong","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2018.10.026_b0190","doi-asserted-by":"crossref","first-page":"G757","DOI":"10.1152\/ajpgi.00442.2014","article-title":"Zinc deficiency mediates alcohol-induced apoptotic cell death in the liver of rats through activating ER and mitochondrial cell death pathways","volume":"308","author":"Sun","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2018.10.026_b0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053028","article-title":"Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment","volume":"8","author":"Bull-Otterson","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2018.10.026_b0200","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.12.019","article-title":"Patients with severe alcoholic hepatitis, prednisolone increases susceptibility to infection and infection-related mortality, and is associated with high circulating levels of bacterial DNA","volume":"152","author":"Vergis","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.10.026_b0205","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1053\/j.gastro.2017.02.030","article-title":"Infection in severe alcoholic hepatitis: yet another piece in the puzzle","volume":"152","author":"Singal","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.10.026_b0210","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.cgh.2016.10.029","article-title":"Healthy donor fecal microbiota transplantation in steroid-ineligible severe alcoholic hepatitis: a pilot study","volume":"15","author":"Philips","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.10.026_b0215","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2018.10.026_b0220","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1172\/JCI60777","article-title":"IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice","volume":"122","author":"Petrasek","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2018.10.026_b0225","first-page":"CD005121","article-title":"Anakinra for rheumatoid arthritis","volume":"1","author":"Mertens","year":"2009","journal-title":"Cochrane Datab Syst Rev"},{"key":"10.1016\/j.jhep.2018.10.026_b0230","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/00003246-199707000-00010","article-title":"Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group","volume":"25","author":"Opal","year":"1997","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jhep.2018.10.026_b0235","first-page":"5","article-title":"Recent advances in the development of Farnesoid X receptor agonists","volume":"3","author":"Ali","year":"2015","journal-title":"Ann Transl Med."},{"key":"10.1016\/j.jhep.2018.10.026_b0240","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1002\/hep.26939","article-title":"Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats","volume":"59","author":"Verbeke","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.10.026_b0245","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrd2619","article-title":"Targeting bile-acid signalling for metabolic diseases","volume":"7","author":"Thomas","year":"2008","journal-title":"Nat Rev Drug Discovery"},{"key":"10.1016\/j.jhep.2018.10.026_b0250","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jhep.2015.11.020","article-title":"Alcohol stimulates macrophage activation through caspase-dependent hepatocyte derived release of CD40L containing extracellular vesicles","volume":"64","author":"Verma","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.10.026_b0255","article-title":"Emricasan improves liver function in patients with cirrhosis and high model for end-stage liver disease scores compared with placebo","author":"Frenette","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.10.026_b0260","doi-asserted-by":"crossref","first-page":"60rv65","DOI":"10.1126\/scitranslmed.3001007","article-title":"The role of JNK proteins in metabolism","volume":"2","author":"Vallerie","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhep.2018.10.026_b0265","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/hep.24599","article-title":"An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice","volume":"54","author":"Mandrekar","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.10.026_b0270","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jhep.2015.06.013","article-title":"Inhibition of sterile danger signals, uric acid and ATP, prevents inflammasome activation and protects from alcoholic steatohepatitis in mice","volume":"63","author":"Iracheta-Vellve","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.10.026_b0275","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1189\/jlb.3AB1214-590R","article-title":"Metabolic danger signals, uric acid and ATP, mediate inflammatory cross-talk between hepatocytes and immune cells in alcoholic liver disease","volume":"98","author":"Petrasek","year":"2015","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jhep.2018.10.026_b0280","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1002\/hep.25873","article-title":"Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases","volume":"56","author":"Bala","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.10.026_b0285","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1111\/acer.12483","article-title":"Micro-RNA-155 deficiency prevents alcohol-induced serum endotoxin increase and small bowel inflammation in mice","volume":"38","author":"Lippai","year":"2014","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhep.2018.10.026_b0290","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/lt.24986","article-title":"Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: a multinational, prospective, controlled, randomized trial","volume":"24","author":"Thompson","year":"2018","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jhep.2018.10.026_b0295","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1053\/j.gastro.2008.08.057","article-title":"A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis","volume":"135","author":"Boetticher","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.10.026_b0300","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.20206","article-title":"A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis","volume":"39","author":"Naveau","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.10.026_b0305","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1055\/s-2008-1073116","article-title":"Acute liver failure: mechanisms of hepatocyte injury and regeneration","volume":"28","author":"Rutherford","year":"2008","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2018.10.026_b0310","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jhep.2015.04.003","article-title":"Hepatic cell proliferation plays a pivotal role in the prognosis of alcoholic hepatitis","volume":"63","author":"Lanthier","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.10.026_b0315","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/hep.28488","article-title":"Liver capsule: mechanisms of alcoholic hepatitis","volume":"64","author":"Schnabl","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.10.026_b0320","article-title":"Review article: cellular abnormalities and emerging biomarkers in alcohol associated liver disease","author":"Singal","year":"2018","journal-title":"Gene Expr"},{"issue":"5 Suppl ISBRA","key":"10.1016\/j.jhep.2018.10.026_b0325","doi-asserted-by":"crossref","first-page":"251S","DOI":"10.1111\/j.1530-0277.2001.tb02404.x","article-title":"Mechanisms of alcoholic liver disease: cytokines","volume":"25","author":"Neuman","year":"2001","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhep.2018.10.026_b0330","doi-asserted-by":"crossref","first-page":"G1019","DOI":"10.1152\/ajpgi.00239.2006","article-title":"IL-22-mediated liver cell regeneration is abrogated by SOCS-1\/3 overexpression in vitro","volume":"292","author":"Brand","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2018.10.026_b0335","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/cmi.2014.2","article-title":"The role of neutrophils in the development of liver diseases","volume":"11","author":"Xu","year":"2014","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jhep.2018.10.026_b0340","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0168-8278(01)00276-8","article-title":"Polymorphonuclear neutrophils are a source of hepatocyte growth factor in patients with severe alcoholic hepatitis","volume":"36","author":"Taieb","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.10.026_b0345","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1136\/gutjnl-2014-308410","article-title":"Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis","volume":"64","author":"Dubuquoy","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2018.10.026_b0350","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2011.11.027","article-title":"Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure","volume":"142","author":"Garg","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.10.026_b0355","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.02.054","article-title":"Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis","volume":"148","author":"Kedarisetty","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.10.026_b0360","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/ajg.2014.154","article-title":"Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study","volume":"109","author":"Singh","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2018.10.026_b0365","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1478-3231.2011.02604.x","article-title":"Antioxidants as therapeutic agents for liver disease","volume":"31","author":"Singal","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2018.10.026_b0370","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","article-title":"Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis","volume":"365","author":"Nguyen-Khac","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2018.10.026_b0375","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jhep.2005.11.039","article-title":"Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis\u2013a randomised clinical trial","volume":"44","author":"Phillips","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.10.026_b0380","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jhep.2007.03.027","article-title":"A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis","volume":"47","author":"Stewart","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.10.026_b0385","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-91316-2","article-title":"Efficacy of granulocyte colony-stimulating factor and n-acetylcysteine therapies in patients with severe alcoholic hepatitis","author":"Singh","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.10.026_b0390","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1665-2681(19)30863-4","article-title":"Treatment with metadoxine and its impact on early mortality in patients with severe alcoholic hepatitis","volume":"13","author":"Higuera-de la Tijera","year":"2014","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhep.2018.10.026_b0395","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"372","author":"Thursz","year":"2015","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.jhep.2018.10.026_b0400","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.clinre.2015.05.008","article-title":"Combination therapy: new hope for alcoholic hepatitis?","volume":"39","author":"Gao","year":"2015","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jhep.2018.10.026_b0405","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/hep.29240","article-title":"Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: a prospective study","volume":"66","author":"Louvet","year":"2017","journal-title":"Hepatology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827818325108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827818325108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:37:45Z","timestamp":1759174665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827818325108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0168827818325108"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2018.10.026","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current trials and novel therapeutic targets for alcoholic hepatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2018.10.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}